Oklahoma 2025 Regular Session

Oklahoma Senate Bill SB913

Introduced
2/3/25  

Caption

Substance abuse services; making certain school training mandatory; requiring boards of education of public school districts to provide certain personnel with emergency opioid antagonists under specified condition. Effective date. Emergency.

Impact

The implementation of SB913 will potentially save lives by ensuring that school personnel are equipped with the necessary tools and knowledge to respond effectively in the event of an opioid overdose on school premises. By mandating that schools provide emergency opioid antagonists and training, the bill seeks to create a safer environment for students and staff. Additionally, this legislation will align with the Good Samaritan Act, which protects individuals administering emergency medications during life-threatening situations, further encouraging proactive responses among school personnel.

Summary

Senate Bill 913 aims to enhance the response to opioid overdoses in Oklahoma public schools by mandating the provision of emergency opioid antagonists, such as naloxone, and training for school personnel. The bill requires the Department of Mental Health and Substance Abuse Services to distribute these emergency medications to public school districts and establishes training programs that adhere to national guidelines for recognizing and responding to opioid overdoses. This legislative measure is part of a broader effort to tackle the opioid crisis affecting many communities across the state.

Contention

The bill has generated some debate regarding the responsibilities placed on school personnel and the implications for school safety protocols. Critics may argue that requiring staff to administer medication could expose them to legal risks or that the potential for misuse of the drugs needs serious consideration. Supporters contend that the benefits of having trained personnel capable of promptly addressing opioid overdoses far outweigh these concerns. The discourse around the bill highlights the broader conversation about how educational institutions can navigate the complexities of health crises while ensuring student safety.

Companion Bills

No companion bills found.

Similar Bills

HI HB310

Relating To Opioid Antagonists.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

MS SB2336

Prevention of overdoses; authorize administration of opioid antagonists by certain persons, provide immunity to.

MS SB2442

Emergency Response and Overdose Prevention Act; amend to expand the distribution and use of opioid antagonists.

MI HB5077

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.

MI HB4366

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106. TIE BAR WITH: HB 4365'23

CA SB472

Pupil health: opioid overdose reversal medication.

TX HB4058

Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.